Honz Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pediatric medicines in China and internationally. It operates through Pharmaceutical Manufacturing and Sales; and Daily Necessities Manufacturing and Sales segments. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal, cough relief, anti-flu, antipyretic-analgesic, anti-infection, anti-fungal, endocrine, anti-allergy, antibacterial and antiviral, respiratory system, digestive system, and gynecological indications, as well as nutritional supplements. It also provides maternal and infant health products; protective and medical masks; and medical devices, including medical protective equipment. In addition, the company engages in investment, property, planting, internet sales, and leasing activities. It markets its products through pharmaceutical distribution agents, sales terminals, and a marketing network. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. was founded in 1993 and is headquartered in Haikou, China.
